Developing the first and only FDA-approved treatment for a particular indication is no longer a guarantee of market access. Before the launch of its first commercial product, one small biotech company was concerned about restrictive utilization management policies. How would its sales team combat barriers to patient access?
The company identified payer coverage monitoring and ongoing analysis of payer responses as its most urgent priorities. The company selected MMIT Analytics to provide payer coverage and restriction data and MMIT Surveillance for real-time alerts about updated policies. They also used Formtrak and Coverage Search to share access details with targeted providers.
Less than a year after achieving FDA approval, the company’s product had already achieved its core launch goals. Read the full case study to learn how.
